Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02272218 · ClinicalTrials.gov registry record · NA
Bariatric Lap Band Surgery as a Treatment for Knee Osteoarthritis
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT02272218: Completed NA study, sponsored by NYU Langone Health.
NCT02272218 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02272218, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The primary purpose of this study is to evaluate laparoscopic gastric banding (LAGB) surgery as a treatment option for obese patients with pain from knee osteoarthritis (KOA) refractory to medical treatment. The primary outcome will be the reduction in OA-related pain and disability after LAGB.
Primary Outcome
questionnaires will be distributed pre- and post-surgery.
Interventions
- PROCEDURE bariatric lap band surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2012-10-23 |
| Est. Completion | 2018-10-18 |
| Phase | NA |
What the finished NCT02272218 record still lists
NCT02272218 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which bariatric lap band surgery is the first listed.
NCT02272218 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02272218 about?
NCT02272218 is a clinical study titled "Bariatric Lap Band Surgery as a Treatment for Knee Osteoarthritis". The primary purpose of this study is to evaluate laparoscopic gastric banding (LAGB) surgery as a treatment option for obese patients with pain from knee osteoarthritis (KOA) refractory to medical treatment. The primary outcome will be the reduction in OA-related pain and disability after LAGB.
What is the current status of trial NCT02272218?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2012-10-23. Estimated completion is 2018-10-18.
What interventions are being tested in trial NCT02272218?
The interventions under investigation include: bariatric lap band surgery (PROCEDURE).
Who is sponsoring clinical trial NCT02272218?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02272218's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI